Tag "biotech stocks"

Inside The Markets: 5 Charts For Active Investors (February 22)

It’s time for another round of macro technical charts as investors attempt to weigh the risk to reward ratio across several markets (including stock market indices, sectors, individual commodities, currencies, bonds, and other benchmarks and market indicators). This chart review will look at 5 charts with important technical price developments.  Even if you’re not…

Biotech ETF (XBI) On The Brink Of A Breakout

The volatility in the biotech space over the last two years has been quite a sight to behold. I’m not strictly speaking of volatility in terms of downside either. There has been money to be made on both sides of the market for those that have been nimble in their…

5 Charts To Watch This Week: Breakouts & Divergences!

It’s time for another set of macro technical charts to watch as we prepare for the month of February (including stock market indices, sectors, individual commodities, currencies, bonds, and other benchmarks and market indicators). This chart review will include 5 charts and look at key technical price developments.  Even if you’re…

Biotech Sector (IBB): A Closer Look At The 2017 Rally

The Nasdaq Biotechnology ETF (NASDAQ:IBB) saw a knee-jerk reaction lower Wednesday after President-elect Donald Trump made harsh comments about drug pricing. On Wednesday, it finished off by -2.99%. While that decline was sharp, and may have hit a few traders, there was a silver lining for opportunistic traders (and I shared this yesterday on my…

Biotechnology Sector Testing Bull Market Trendline

When this market cycle finally comes to an end, among the sectors that will be remembered as one of its key drivers is biotechnology. With a gaudy 750% gain since its 2009 lows, the Biotech run had been so hot, it attracted “bubble” talk in its descriptions, including by us back…

Gilead Sciences (GILD): Fundamentals vs Technicals

About $7 ago, I tweeted that Gilead Sciences stock (NASDAQ:GILD) was starting to present a real conundrum of fundamentals/valuation (positive) vs. technicals (negative). So far the technicals (and specifically DeMark indicators) have prevailed. But ignoring Gilead Sciences stock fundamentals (valuation and balance sheet) is becoming increasingly difficult. If you are…

Biotech Sector M&A Breakdown: Stocks To Watch

The Biotech Sector (NASDAQ:IBB) has been volatile the last few weeks, more so than the market at least with two opposing forces. On one side, sell-offs look to be election related on fears of further scrutiny on drug pricing weighing on future profits, and on the other side, a growing…

Biotechnology Index BTK Trading Near Critical Price Level

A key index of biotechnology stocks may be approaching significant levels of resistance. Throughout the course of the post-February rally, one topic that has been bandied about (including by us) is the question of a new bull market up-leg vs. a bear market rally. At the root of the question…